Document is current
Any future updates will be listed below
-
Authors
Pujol, Pascal
Vande Perre, Pierre http://orcid.org/0000-0001-7595-7243
Faivre, Laurence
Sanlaville, Damien
Corsini, Carole
Baertschi, Bernard
Anahory, Michèle
Vaur, Dominique
Olschwang, Sylviane
Soufir, Nadem
Bastide, Noëlle
Amar, Sarah
Vintraud, Michèle
Ingster, Olivier
Richard, Stéphane
Le Coz, Pierre
Spano, Jean-Philippe
Caron, Olivier
Hammel, Pascal
Luporsi, Elisabeth
Toledano, Alain
Rebillard, Xavier
Cambon-Thomsen, Anne http://orcid.org/0000-0001-8793-3644
Putois, Olivier
Rey, Jean-Marc
Hervé, Christian
Zorn, Caroline
Baudry, Karen
Galibert, Virginie
Gligorov, Joseph
Azria, David
Bressac-de Paillerets, Brigitte
Burnichon, Nelly
Spielmann, Marc
Zarca, Daniel
Coupier, Isabelle
Cussenot, Olivier
Gimenez-Roqueplo, Anne-Paule
Giraud, Sophie
Lapointe, Anne-Sophie
Niccoli, Patricia
Raingeard, Isabelle
Le Bidan, Muriel
Frebourg, Thierry
Rafii, Arash
Geneviève, David
- License Information
-
More Information
Article History
Received: 27 February 2018
Accepted: 5 July 2018
First Online: 8 August 2018
Compliance with ethical standards
:
: The authors declare no conflicts of interest with industry or firms commercializing genetic tests. No industry or corporate sponsors contributed to the development of these recommendations. SFMPP is not funded by industrial or commercial companies but by grants from public institutions and partially self-funded by SFMPP annual congresses. Dr. Pujol discloses attending Advisory Board Membership meetings for AstraZeneca, Pfizer, and Genomic Health.
